hepatitis-c

Documents about hepatitis-c

• Barriers and facilitators to hepatitis C patient engagement: Interview study with general practitioner champions in England#358738PLOS
• Hepatitis C distribution across diverse population groups in the Eastern Mediterranean Region: An umbrella review#121530PLOS
• A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects#874039ClinicalTrials.gov
• A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients#853326ClinicalTrials.gov
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#141265PLOS
• Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir#883389ClinicalTrials.gov
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C#887487ClinicalTrials.gov
• CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects#904682ClinicalTrials.gov
• Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia#859857ClinicalTrials.gov
• Examining Hepatitis C Reinfection Rates in Kenya#893820ClinicalTrials.gov
• Hepatitis C Rimantadine and Antiviral Combination Therapy#888313ClinicalTrials.gov
• Electronic Record Assimilation and Subsequent Eradication of Hepatitis C#993082ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection#995214ClinicalTrials.gov
• Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus#912645ClinicalTrials.gov
• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• Directly Observed Hepatitis C Treatment in Methadone Clinics#878200ClinicalTrials.gov
• Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants#877410ClinicalTrials.gov
• Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients#875483ClinicalTrials.gov
• Vitamin D Treatment in Patients With Chronic Hepatitis C#912767ClinicalTrials.gov
• Combating Related Epidemics in HCV#881744ClinicalTrials.gov
• Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot#897577ClinicalTrials.gov
• The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients#828942ClinicalTrials.gov
• Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C#847092ClinicalTrials.gov
• Cellular immune signatures of clinical outcome in hepatitis C virus infection#1005594The University of Melbourne Library Digital Repository
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis#857029ClinicalTrials.gov
• Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C#844530ClinicalTrials.gov
• Direct-acting antiviral therapy is associated with a reduced risk of selected immune-mediated inflammatory diseases in chronic hepatitis C infection: A real-world cohort study#313063PLOS
• Hepatitis C: Grading and Staging by MR#845466ClinicalTrials.gov
• Study of a Novel Therapeutic Vaccine for Hepatitis C Virus#208253ClinicalTrials.gov
• Pathology of Hepatitis c Nephropathy#812446ClinicalTrials.gov
• Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C#903962ClinicalTrials.gov
• Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)#907201ClinicalTrials.gov
• A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection#846448ClinicalTrials.gov
• Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV#872747ClinicalTrials.gov
• Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C#1008301ClinicalTrials.gov
• Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients#862071ClinicalTrials.gov
• Quantification of Side Effects During Hepatitis C Therapy#887244ClinicalTrials.gov
• Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1#967025ClinicalTrials.gov
• DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection#154726ClinicalTrials.gov
• Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar#1008172ClinicalTrials.gov
• Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients#834264ClinicalTrials.gov
• Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography#849147ClinicalTrials.gov
• A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)#125946ClinicalTrials.gov
• Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1#859600ClinicalTrials.gov
• Study of Hepatitis C Treatment During Pregnancy#891210ClinicalTrials.gov
• Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children#800203ClinicalTrials.gov
• Evaluation of the National Treatment Program of Hepatitis C in Egypt#806154ClinicalTrials.gov
• Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2#826060ClinicalTrials.gov
• Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants#895795ClinicalTrials.gov
• Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs#978859ClinicalTrials.gov

Related topics